4.6 Editorial Material

Learning lessons from the COVID-19 pandemic for real-world evidence research in oncologydshared perspectives from international consortia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Oncology

ASCO Living Guidelines: The Next Frontier

Veda N. Giri et al.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Computer Science, Artificial Intelligence

Assessing the communication gap between AI models and healthcare professionals: Explainability, utility and trust in AI-driven clinical decision-making

Oskar Wysocki et al.

Summary: This study presents a pragmatic evaluation framework for explainable Machine Learning (ML) models in clinical decision support. The findings reveal both positive and negative effects of ML explanation models when embedded in the clinical context. However, the study also identifies significant positive effects, such as reducing automation bias and supporting less experienced healthcare professionals in acquiring new domain knowledge.

ARTIFICIAL INTELLIGENCE (2023)

Article Oncology

Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials

J. L. Perez-Gracia et al.

Summary: In recent years, the burden of bureaucracy in clinical research has significantly increased, negatively impacting investigators and clinical research teams. While compliance with regulations and guidelines is important, the overinterpretation and substitution by sponsors and CROs have increased administrative burden. A survey among 940 investigators confirmed excessive administrative burden and bureaucracy as obstacles to clinical research.

ANNALS OF ONCOLOGY (2023)

Review Urology & Nephrology

Therapeutic advances in COVID-19

Naoka Murakami et al.

Summary: This article evaluates different types of therapies for treating COVID-19, with a particular focus on their relevance to patients with kidney failure and kidney transplant recipients. The research finds that anti-inflammatory and antiviral agents have a stronger evidence base and greater benefits compared to other therapeutic approaches.

NATURE REVIEWS NEPHROLOGY (2023)

Article Immunology

Clinical development and approval of COVID-19 vaccines

Ulrich Kalinke et al.

Summary: This article discusses several factors that led to the accelerated development and approval of COVID-19 vaccines, including process optimization, redesign of sequential development processes, learning from previous pandemics, and prior development of novel vaccine platforms. Despite complex challenges, important milestones were achieved within a short period, and the approved vaccines have been proven to be safe and effective on a global scale.

EXPERT REVIEW OF VACCINES (2022)

Article Oncology

COVID-19 in patients with cancer: first report of the ESMO international registry-based, cohort study (ESMO-CoCARE)

L. Castelo-Branco et al.

Summary: This study aimed to investigate the natural history, management, and outcomes of cancer patients infected with COVID-19. The study found that factors such as sex, age, cancer stage, body mass index, and comorbidities were associated with the severity and prognosis of COVID-19 in cancer patients.

ESMO OPEN (2022)

Review Pharmacology & Pharmacy

Wearable smart devices in cancer diagnosis and remote clinical trial monitoring: Transforming the healthcare applications

Sarwar Beg et al.

Summary: The era of digitalization has greatly advanced pharmaceutical device manufacturing, with wearable devices using IoT sensors gaining popularity for real-time monitoring of health data. These devices, integrated with smart materials, are proving to be cost-effective tools for remote clinical trial monitoring.

DRUG DISCOVERY TODAY (2022)

Article Oncology

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future

G. Kreye et al.

Summary: This study analyzed the situation of cancer patients infected with COVID-19 in Belgium and found factors related to patient survival.

ESMO OPEN (2022)

Article Public, Environmental & Occupational Health

Publication and Impact of Preprints Included in the First 100 Editions of the CDC COVID-19 Science Update: Content Analysis

Jeremy Otridge et al.

Summary: The study evaluated the publication rate and impact of preprints included in the CDC COVID-19 Science Update, finding that high-quality preprints had a higher chance of being published and had a greater impact.

JMIR PUBLIC HEALTH AND SURVEILLANCE (2022)

Article Computer Science, Artificial Intelligence

Explanatory artificial intelligence (YAI): human-centered explanations of explainable AI and complex data

Francesco Sovrano et al.

Summary: This paper introduces a new class of software tools, called cumulatively Explanatory AI (YAI) systems, which provide successful explanations of complex processes on top of basic Explainable AI (XAI) software systems. The YAI systems enhance the quality of XAI output by adopting a user-centred approach to explanation, catering to the individual needs of explainees and improving usability. The paper presents the theoretical foundations of YAI, defining a user-centred explanatory tool and the space of all possible explanations. It also provides empirical results to support the theory, demonstrating that explanations go beyond textual or visual presentations of XAI information.

DATA MINING AND KNOWLEDGE DISCOVERY (2022)

Article Medicine, General & Internal

Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce

Heath White et al.

Summary: The Australian National COVID-19 Clinical Evidence Taskforce provides up-to-date treatment recommendations for non-pregnant adults with COVID-19. The guideline includes recommendations for severe/critical or mild disease, covering therapy, prophylaxis, respiratory support, and supportive care. The latest version recommends specific drug treatments based on disease severity.

MEDICAL JOURNAL OF AUSTRALIA (2022)

Article Health Care Sciences & Services

European Health Data Space-An Opportunity Now to Grasp the Future of Data-Driven Healthcare

Denis Horgan et al.

Summary: The European Commission has proposed a 'European health data space' to harness the benefits of the growing health data in Europe. However, there are clarifications needed to ensure success, including freeing data, gaining trust from patients and citizens, and promoting wide engagement.

HEALTHCARE (2022)

Proceedings Paper Materials Science, Multidisciplinary

Analyzing the impact of machine learning and artificial intelligence and its effect on management of lung cancer detection in covid-19 pandemic

Raja Sarath Kumar Boddu et al.

Summary: Cancer patients, especially those with lung cancer, are more susceptible to COVID-19 due to their compromised immune systems, leading to complex and time-consuming diagnosis, treatment, and care during an epidemic. Advances in artificial intelligence and machine learning offer potential to enhance cancer patient care, diagnosis, and treatment.

MATERIALS TODAY-PROCEEDINGS (2022)

Article Multidisciplinary Sciences

Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly

Diego Anazco et al.

Summary: This study found a remarkably low publication rate for COVID-19-related preprints within the sample, despite accelerated publication times by scholarly journals. Additionally, preprints showed significantly lower scientific impact, indicating that some may not meet quality standards for peer-reviewed journal publication.
Article Oncology

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

P. Grivas et al.

Summary: This study analyzed clinical factors and laboratory measurements of cancer patients with COVID-19, finding that factors such as age, sex, comorbidities, cancer type, and laboratory results were associated with COVID-19 severity. Patients diagnosed early in the pandemic had worse outcomes, and specific anticancer therapies may increase 30-day all-cause mortality. More research is needed to confirm these findings and caution may be needed in using certain anticancer treatments.

ANNALS OF ONCOLOGY (2021)

Article Oncology

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study

David J. Pinato et al.

Summary: Despite high contagiousness and rapid spread, SARS-CoV-2 has led to heterogeneous outcomes across nations, with UK being the most severely affected in Europe. UK cancer patients with COVID-19 had higher case fatality rates and risk of death compared to EU counterparts, with differences in patient characteristics, therapy, and outcomes. Further evaluation of long-term impacts and prioritization for vaccination is needed for high-risk groups.

EUROPEAN JOURNAL OF CANCER (2021)

Article Multidisciplinary Sciences

Swarm Learning for decentralized and confidential clinical machine learning

Stefanie Warnat-Herresthal et al.

Summary: The study introduces Swarm Learning, a decentralized machine-learning approach that integrates medical data globally while complying with local privacy regulations. Using over 16,400 blood transcriptomes and more than 95,000 chest X-ray images, the research shows that Swarm Learning classifiers outperform those developed at individual sites.

NATURE (2021)

Review Health Care Sciences & Services

Application of Artificial Intelligence in COVID-19 Diagnosis and Therapeutics

Ken Asada et al.

Summary: The COVID-19 pandemic has led to a global focus on utilizing artificial intelligence technology in medical research to combat the threat. Numerous studies have demonstrated significant success in applying AI to tasks such as disease classification, detection, and prediction.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Editorial Material Oncology

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration Comment

Jennifer G. Whisenant et al.

CANCER CELL (2020)

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Review Health Care Sciences & Services

The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review

Ulrikke Lyng Beauchamp et al.

JMIR MHEALTH AND UHEALTH (2020)

Review Oncology

Real-world data: towards achieving the achievable in cancer care

Christopher M. Booth et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)